VLP THE VACCINES COMPANY (VLPbio)

PCV2 (Porcine circovirus type 2)

VLPbio’s multi-disciplinary team of experts are leading the immunogenicity and challenge studies on pigs for new vaccine candidates against PCV2. The production process have been already developed with high yields and reduced costs

Infectious Diseases

4R&D

Spain